Scientists from the University of Chile Veterinary and Livestock
Faculty developed the vaccine from an existing formula used to
sterilize pigs, as professor Leonardo Saenz explains.
"It began in Australia more or less in 1989. What we did was to take
the concept of immuno-castration which already existed and we
developed and improved for use in domestic animals, mainly in dogs,
and to create an alternative for pigs, better than what already
exists. The previous one was a vaccine by a pharmaceutical
laboratory which needs two doses to take effect. In our case, only
one dose is needed for the vaccine to take effect," said Saenz.
According to Saenz, the effect of the vaccine is similar to that of
a surgical castration without needing the resources and subsequent
care such an operation requires.
It is also a reversible measure based on hormonal alterations.
"The vaccine is a recombinant protein generated in Escherichia coli.
The protein is carried by inclusive bodies which are purified
previously in Escherichia coli, and we create the vaccine using a
polymer. Chitosan is used for pigs and this formula permits, or
induces the formation of anti-bodies which neutralize the hormone
Betatrophin, and these neutralizing anti-bodies prevent reproductive
activity. There is no Progesterone or Estrogen in the females and no
Testosterone in the males, which blocks reproductive activity and is
a form of immunological castration," said Saenz.
Veterinary scientists hope the vaccine will help to control the
growing canine population in Chile, where surgical castration is
only applied in small numbers. They expect the vaccine could be
administered to a group three or four times greater than those that
undergo surgery.
A further benefit of the vaccine, according to scientists, is that
it has no side effects, unlike other forms of contraception.
[to top of second column] |
"Since it is a vaccine which blocks the production of hormones, it
does not function as a contraceptive but rather an immuno-castrator.
The difference is that contraceptives prevent animals from going on
heat. It will still engage in reproductive activity but it will not
be able to fertilize. In this case, there are no hormones so there
is no activity, there are no gametes so the animal is sterilized as
a result of suppressed hormones. As there is a reduction in the
hormonal activity, there are no side effects as is the case with
hormonal contraceptives on which they put high quantities of
contraceptive or hormones which induce alterations in the uterus and
can be related to the appearance of some cancers. In this case that
does not happen, we block that activity," said Saenz.
The vaccine has been patented in Chile, Europe and the United
States, and is undergoing further tests in controlled conditions. In
Chile, the final formula will have to be authorized by the
Agricultural and Livestock Service, before it is commercialized.
A number of other dog vaccines are currently under development
globally, including one at the California Institute of Technology
and another being tested by Oklahoma-based Spay First and the U.S.
Department of Agriculture's National Wildlife Research Center.
[© 2015 Thomson Reuters. All rights
reserved.]
Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|